Curt Bradshaw, Chief Scientific Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 62,500 shares at $68.73 ($4.3M) on 2020-11-20, disclosed to the SEC on 2020-11-23.
Open-market sale of $4.3M ARWR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.39 | 15,625 | $1.1M | 25.1% |
| 2 | $69.39 | 15,625 | $1.1M | 25.1% |
| 3 | $68.73 | 15,625 | $1.1M | 24.9% |
| 4 | $68.73 | 15,625 | $1.1M | 24.9% |
| Total | $69.06 avg | 62,500 | $4.3M | 100% |